These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27003666)

  • 1. New Therapeutic Paradigms and Guidelines in the Management of Pulmonary Arterial Hypertension.
    Hill NS; Cawley MJ; Heggen-Peay CL
    J Manag Care Spec Pharm; 2016 Mar; 22(3 Suppl A):S3-21. PubMed ID: 27003666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy in the management of pulmonary arterial hypertension.
    Buckley MS; Staib RL; Wicks LM
    Int J Clin Pract Suppl; 2013 May; (179):13-23. PubMed ID: 23578069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018.
    Hoeper MM; Apitz C; Grünig E; Halank M; Ewert R; Kaemmerer H; Kabitz HJ; Kähler C; Klose H; Leuchte H; Ulrich S; Olsson KM; Distler O; Rosenkranz S; Ghofrani HA
    Int J Cardiol; 2018 Dec; 272S():37-45. PubMed ID: 30190158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Clinical Trial Endpoints of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension and How They Relate to Patient Outcomes in the United States.
    Divers C; Platt D; Wang E; Lin J; Lingohr-Smith M; Mathai SC
    J Manag Care Spec Pharm; 2017 Jan; 23(1):92-104. PubMed ID: 28025931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations for optimal management of patients with pulmonary arterial hypertension: a multi-stakeholder roundtable discussion.
    Studer SM; Kingman M; Calo L; Cannon HE; Dunn JD; James T; Lewis SJ; Gilkin RJ; Pruett JA
    Am J Manag Care; 2017 May; 23(6 Suppl):S95-S104. PubMed ID: 28715904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Pulmonary Arterial Hypertension.
    Weatherald J; Varughese RA; Liu J; Humbert M
    Semin Respir Crit Care Med; 2023 Dec; 44(6):746-761. PubMed ID: 37369218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current clinical management of pulmonary arterial hypertension.
    Zamanian RT; Kudelko KT; Sung YK; Perez VJ; Liu J; Spiekerkoetter E
    Circ Res; 2014 Jun; 115(1):131-147. PubMed ID: 24951763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap.
    McLaughlin VV; Langer A; Tan M; Clements PJ; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ;
    Chest; 2013 Feb; 143(2):324-332. PubMed ID: 22910999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines.
    Dinarti LK; Anggrahini DW; Lilyasari O; Siswanto BB; Hartopo AB
    Glob Heart; 2021 Apr; 16(1):23. PubMed ID: 34040936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.
    Waxman AB; Zamanian RT
    Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update.
    Johnson SG; Kayser SR; Attridge RL; Duvall L; Kiser TH; Moote R; Reed BN; Rodgers JE; Erstad B
    Pharmacotherapy; 2012 Jun; 32(6):e134-69. PubMed ID: 22467427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy in pulmonary arterial hypertension: is this the new standard of care?
    Ruiz G; Besinque GM; Lickert CA; Raspa S
    Am J Manag Care; 2015 Jun; 21(8 Suppl):s151-61. PubMed ID: 26168371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase 5 inhibitors for pulmonary hypertension.
    Barnes H; Brown Z; Burns A; Williams T
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012621. PubMed ID: 30701543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial designs in PAH: shifting from functional measurements to long-term clinical outcomes.
    Studer SM; Gilkin RJ
    Am J Manag Care; 2014 Mar; 20(6 Suppl):S115-22. PubMed ID: 24716456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pharmacotherapy options for pulmonary arterial hypertension.
    Perrin S; Chaumais MC; O'Connell C; Amar D; Savale L; Jaïs X; Montani D; Humbert M; Simonneau G; Sitbon O
    Expert Opin Pharmacother; 2015; 16(14):2113-31. PubMed ID: 26290279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Arterial Hypertension: Combination Therapy in Practice.
    Burks M; Stickel S; Galiè N
    Am J Cardiovasc Drugs; 2018 Aug; 18(4):249-257. PubMed ID: 29511993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolving treatment landscape of pulmonary arterial hypertension.
    Gale S
    Am J Manag Care; 2021 Mar; 27(3 Suppl):S42-S52. PubMed ID: 33710843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.